Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Berry

Showing results (531-540 of 698) with videos related to

Pageof 70
Sort By:
Toxicology Letters|January 7, 2021
Critique of the "Comment" etitled "Pyrethroid exposure: Not so harmless after all" by Demeneix et al. (2020) published in the lancet diabetes endocrinologyFrank A Barile, Sir Colin Berry, Bas Blaauboer, et al.
JAMA Cardiology|June 23, 2021
Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection FractionChristopher J Rush, Colin Berry, Keith G Oldroyd, et al.
JACC. Cardiovascular Interventions|July 23, 2018
Sex Differences in Adenosine-Free Coronary Pressure Indexes: A CONTRAST SubstudySonia V Shah, Frederik M Zimmermann, Nils P Johnson, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 27, 2020
Veno-arterial extracorporeal membrane oxygenation (ECMO) in patients with cardiogenic shock: rationale and design of the randomised, multicentre, open-label EURO SHOCK trialAmerjeet Singh Banning, Tom Adriaenssens, Colin Berry, et al.
Journal of the American College of Cardiology|October 21, 2017
Agreement of the Resting Distal to Aortic Coronary Pressure With the Instantaneous Wave-Free RatioYuhei Kobayashi, Nils P Johnson, Frederik M Zimmermann, et al.
JCI Insight|October 5, 2016
Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarctionDavid Carrick, Caroline Haig, Jaclyn Carberry, et al.
Open Heart|April 26, 2016
Non-invasive versus invasive management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: study design of the pilot randomised controlled trial and registry (CABG-ACS)Matthew M Y Lee, Mark C Petrie, Paul Rocchiccioli, et al.
European Heart Journal|August 12, 2025
Coronary function testing vs angiography alone to guide treatment of angina with non-obstructive coronary arteries: the ILIAS ANOCA trialCoen K M Boerhout, Hanae F Namba, Tommy Liu, et al.
Chemico-Biological Interactions|May 7, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Toxicology Letters|May 4, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Pageof 70

Showing results (531-540 of 698) with videos related to

Sort By:
Pageof 70
Toxicology Letters|January 7, 2021
Critique of the "Comment" etitled "Pyrethroid exposure: Not so harmless after all" by Demeneix et al. (2020) published in the lancet diabetes endocrinologyFrank A Barile, Sir Colin Berry, Bas Blaauboer, et al.
JAMA Cardiology|June 23, 2021
Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection FractionChristopher J Rush, Colin Berry, Keith G Oldroyd, et al.
JACC. Cardiovascular Interventions|July 23, 2018
Sex Differences in Adenosine-Free Coronary Pressure Indexes: A CONTRAST SubstudySonia V Shah, Frederik M Zimmermann, Nils P Johnson, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 27, 2020
Veno-arterial extracorporeal membrane oxygenation (ECMO) in patients with cardiogenic shock: rationale and design of the randomised, multicentre, open-label EURO SHOCK trialAmerjeet Singh Banning, Tom Adriaenssens, Colin Berry, et al.
Journal of the American College of Cardiology|October 21, 2017
Agreement of the Resting Distal to Aortic Coronary Pressure With the Instantaneous Wave-Free RatioYuhei Kobayashi, Nils P Johnson, Frederik M Zimmermann, et al.
JCI Insight|October 5, 2016
Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarctionDavid Carrick, Caroline Haig, Jaclyn Carberry, et al.
Open Heart|April 26, 2016
Non-invasive versus invasive management in patients with prior coronary artery bypass surgery with a non-ST segment elevation acute coronary syndrome: study design of the pilot randomised controlled trial and registry (CABG-ACS)Matthew M Y Lee, Mark C Petrie, Paul Rocchiccioli, et al.
European Heart Journal|August 12, 2025
Coronary function testing vs angiography alone to guide treatment of angina with non-obstructive coronary arteries: the ILIAS ANOCA trialCoen K M Boerhout, Hanae F Namba, Tommy Liu, et al.
Chemico-Biological Interactions|May 7, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Toxicology Letters|May 4, 2020
Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?Herman Autrup, Frank A Barile, Sir Colin Berry, et al.
Pageof 70